Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients.

Bustanul ArifinFredrick Dermawan PurbaHendra HermanJohn M F AdamJarir AtthobariCatharina C M Schuiling-VeningaPaul F M KrabbeMaarten J Postma

Published in: Health and quality of life outcomes (2020)

This study suggests that the 5 L-version of the EQ-5D instrument performs better than the 3 L-version in T2DM outpatients in Indonesia, regarding measurement and scoring properties. As such, our study supports the use of the 5 L as the preferred health-related quality of life measurement tool. We did not do a trial but this study was approved by the Medical Ethics Committee of Universitas Gadjah Mada Yogyakarta, Indonesia (document number KE/FK/1188/EC, 12 November 2014, amended 16 March 2015).

Keyphrases

healthcare
end stage renal disease
clinical trial
chronic kidney disease
randomized controlled trial
type diabetes
machine learning
ejection fraction
patient reported outcomes
skeletal muscle
glycemic control
psychometric properties
drug administration
anaerobic digestion